TY - JOUR
T1 - The diagnosis and management of anaphylaxis
T2 - An updated practice parameter
AU - Lieberman, Phillip
AU - Kemp, Stephen F.
AU - Oppenheimer, John
AU - Lang, David M.
AU - Bernstein, I. Leonard
AU - Nicklas, Richard A.
AU - Anderson, John A.
AU - Bernstein, David I.
AU - Bernstein, Jonathan A.
AU - Fink, Jordan N.
AU - Greenberger, Paul A.
AU - Ledford, Dennis K.
AU - Li, James
AU - Sheffer, Albert L.
AU - Solensky, Roland
AU - Wolf, Bruce L.
AU - Blessing-Moore, Joann
AU - Khan, David A.
AU - Lee, Rufus E.
AU - Portnoy, Jay M.
AU - Schuller, Diane E.
AU - Spector, Sheldon L.
AU - Tilles, Stephen A.
PY - 2005/3
Y1 - 2005/3
N2 - These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology; the American College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology. The American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) have jointly accepted responsibility for establishing "The diagnosis and management of anaphylaxis: an updated practice parameter." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion. This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients.
AB - These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology; the American College of Allergy, Asthma and Immunology; and the Joint Council of Allergy, Asthma and Immunology. The American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI) have jointly accepted responsibility for establishing "The diagnosis and management of anaphylaxis: an updated practice parameter." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma and Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion. This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients.
UR - http://www.scopus.com/inward/record.url?scp=20044364732&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20044364732&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2005.01.010
DO - 10.1016/j.jaci.2005.01.010
M3 - Review article
C2 - 15753926
AN - SCOPUS:20044364732
SN - 0091-6749
VL - 115
SP - S483-S523
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 3 SUPPL. 2
ER -